Epidemiological investigation of infection cases in children with hepatitis C virus in the Department of Hematological Oncology of the healthcare facility

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

To prevent the transmission of social blood-borne infections that can be transmitted during medical care and to identify the factors that create a threat of transmission of pathogens remain an important task for the facilities of the Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being. Objective. To conduct an epidemiological investigation of cases of suspected infection in children with hepatitis C virus (HCV) during medical care, to study the ways and risk factors for infection in children, to identify the likely source of infection and the site of a chronic lesion with multiple cases of hepatitis C. Materials and methods. The investigation was conducted by the Directorate for the Amur Region, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, with organizational and methodological assistance from the Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, in 2018-2019. The investigators carried out a retrospective analysis of more than 8500 units of the 1997 to 2018 medical records, search and examination for HCV/HBVin 2706 out of4899 contact persons, genotyping and phylogenetic analysis of160samples, including those from 99 affected children, and laboratory studies of the objects of the external environment and health care facilities. The reasons for the occurrence of cases of blood-borne infections associated with the provision of medical care were analyzed to implement a set of preventive and anti-epidemic measures. Results. A total of 169 children were identified as suspected to be infected with HCV when receiving medical care in a hospital. To establish the reasons for the formation of a long-term focus of hepatitis C, the investigators eliminated the possibility of perinatally contaminating the children with HCV from mothers or family members through household contact, transmission of this virus during blood component transfusions, as well as its transmission from healthcare staff during professional or household contact. In the department, to where all infected children were admitted, the healthcare staff was retrospectively and promptly established to have violated the vascular catheter care rules and the hygienic handwashing ones during medical procedures, the timing and types of examination of patients for HCV, the disinfection of medical devices and to have made a number of other violations, including failure to provide timely information on new-onset hepatitis C cases in children. There was poor provision of hospital departments with disinfectants, antiseptics, and disposable medical products. The same (leading) HCV genotype 3a was detected in 96.1% of the affected children; HCV genotype 1b was seen in 3 children. Molecular biological studies significantly established an epidemiological relationship among 97.2% of the children infected with HCV genotype 3a. The epidemiological relationship was also confirmed between children with HCV genotype 1b. Conclusion. The artificial mechanism of transmitting the infection has been revealed during invasive medical interventions. The factors of its transmission were medical tools and consumables contaminated with the blood of children with hepatitis C. A child who had 15 admissions to the Department of Hematological Oncology from 1996 to 2013 has been found to be most likely a source of infection for most of the others.

Full Text

Restricted Access

About the authors

Natalia N. Ladnaia

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: nladnaia@hotmail.com
Cand. Biol. Sci., Senior Researcher, Department of Epidemiology and Prevention of AIDS

Larisa A. Dementyeva

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: dementeva_la@gsen.ru
Specialist in Epidemiology

Olga P. Kurganova

Directorate for the Amur Region, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: info@rospotrebnadzor-amur.ru
Cand. Med. Sci., Head, Directorate for the Amur Region

Antonina A. Ploskireva

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: antonin@ploskirena.com
MD, Deputy Director for Clinical Work

Nikolai N. Pimenov

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: n.pimenov@mail.ru
Cand. Med. Sci., Junior Researcher, Laboratory of Viral Hepatitis, Department of Molecular Diagnostics and Epidemiology

Ekaterina N. Burdinskaya

Center for Hygiene and Epidemiology in the Amur Region

Email: epidotd@cge-amur.ru
Deputy Chief Physician

Olesya M. Yurgina

Center for Hygiene and Epidemiology in the Amur Region

Email: office@cge-amur.ru
Chief Physician

Nadezhda V. Kozyrina

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: nad-kozyrina@yandex.ru
Cand. Med. Sci., Senior Researcher, Department of Epidemiology and Prevention of AIDS

Ekaterina V. Sokolova

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: ekaterinasokolova007@rambler.ru
Cand. Med. Sci., Researcher, Department of Epidemiology and Prevention of AIDS

Vladimir P. Chulanov

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: vladimir@chulanov.ru
МD, Head, Scientific Advisory Clinical Diagnostic Center

Anna D. Muzyka

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: nikolitch-anna@yandex.ru
Cand. Med. Sci., Senior Researcher, Clinical Department of Infectious Pathology

Svetlana V. Komarova

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: komarovasv@nmrc.ru
Researcher, Laboratory of Viral Hepatitis, Department of Molecular Diagnostics and Epidemiology

Vadim V. Pokrovsky

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: pokrovsky.vad@yandex.ru
Academician of the Russian Academy of Sciences, MD, Head, HIV Department

Anna Yu. Popova

Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

МD, Head

Elena B. Ezhlova

Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Cand. Med. Sci., Deputy Head

E. P Igonina

Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: igonina_ep@rospotrebnadzor.ru

Asiliy G. Akimkin

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Academician of the Russian Academy of Sciences, MD, Director

References

  1. Найговзина Н.Б., Попова А.Ю., Бирюкова Е.Е., Ежлова Е.Б., Игонина Е.П., Покровский В.И. и др. Оптимизация системы мер борьбы и профилактики инфекций, связанных с оказанием медицинской помощи, в Российской Федерации. Эпидемиол. инфекц. болезни. Актуал. вопр. 2018; (1); 6-14
  2. Покровский В.И.,Акимкин В.Г., Брико Н.И., Брусина Е.Б., Зуева Л.П., Ковалишена О.В. и др. Национальная концепция профилактики инфекций, связанных с оказанием медицинской помощи. Н. Новгород, 2012. 84 с
  3. О состоянии санитарно-эпидемиологического благополучия населения в Российской Федерации в 2021 году. Государственный доклад. М., 2022. 340 с
  4. Социально значимые заболевания населения России в 2019 году (Статистические материалы), Министерство здравоохранения Российской Федерации. М., 2020. 77 с
  5. Нечаева О.Б. Социально значимые инфекционные заболевания, представляющие биологическую угрозу населению России. Туберкулез и болезни легких 2019; 97(11): 7-17. http://doi.org/10.21292/2075-1230-2019-9711-7-17
  6. Попова А.Ю., Ежлова Е.Б., Игонина Е.П., Мельникова А.А., Фролова Н.В. Надзор за соблюдением санитарно-эпидемиологического законодательства при оказании медицинской помощи в целях обеспечения ее качества и безопасности. Вестник Росздравнадзора 2016; (1): 74-8
  7. Sinchez-Tapias J.M. Nosocomial transmission of hepatitis C. virus. J. Hepatol. 1999; 31(Suppl 1): 107-12. doi: 10.1016/s0168-8278(99)80385-7; PMID: 10622571
  8. Ganczak M., Barss P. Nosocomial HIV infection: epidemiology and prevention--a global perspective. AIDS Rev. 2008; 10(1): 47-61. PMID: 18385780
  9. Thompson N.D., Perz J.F., Moorman A.C., Holmberg S.D. Nonhospital health care-associated hepatitis B. and C. virus transmission: United States, 1998-2008. Ann. Int. Med. 2009; 150(1): 33-9. doi: 10.7326/0003-4819-150-1-200901060-00007
  10. Chung Y.S., Choi J.Y., Han M.G., Park K.R., Park S.J., Lee H.G. et al. A large healthcare-associated outbreak of hepatitis C. virus genotype 1a in a clinic in Korea. J. Clin. Virol. 2018; 106: 53-7. doi: 10.1016/j.jcv.2018.07.006.
  11. Bruguera M., Saiz J.C., Franco S., Gim6nez-Barcons M., Sinchez-Tapias J.M., Fabregas S. et al. Outbreak of nosocomial hepatitis C. virus infection resolved by genetic analysis of HCV RNA. J. Cli.n Microbiol. 2002; 40(11): 4363-6. doi: 10.1128/JCM.40.11.4363-4366.2002; PMID: 12409433; PMCID: PMC139636
  12. Folkema A., Wang H.L., Wright K., Hirji M.M., Andonov A., Bromley K. et al. An outbreak of hepatitis C. virus attributed to the use of multi-dose vials at a colonoscopy clinic, Waterloo Region, Ontario. Can. Commun. Dis. Rep. 2021; 47(4): 224- 31. doi: 10.14745/ccdr.v47i04a07; PMID: 34035670; PMCID: PMC812769
  13. Покровский В.В., Ерамова И.Ю., Деулина М.О. Внутрибольничная вспышка ВИЧ-инфекции в Элисте. Журнал микробиологии, эпидемиологии и иммунобиологии 1990; 67(4): 17-23. Pokrovsky VV., Eramova I.Yu., Deulina M.O. [Nosocomial outbreak of HIV infection in Elista]. Journal of Microbiology, Epidemiology and Immunobiology 1990; 67(4): 17-23. (In Russ.).
  14. Mir F., Nathwani A.A., Simms V., Abidi S.H., Siddiqui A.R., Hotwani A. et al. Factors associated with HIV infection among children in Larkana District, Pakistan: a matched case-control study. Lancet HIV 2021; 8(6): e342-e352. doi: 10.1016/S2352-3018(21)00049-7; PMID: 34087096
  15. Ладная Н.Н., Покровский В.В., Дементьева Л.А., Соколова Е.В., Нарсия Р.С. Передача ВИЧ-инфекции, связанная с оказанием медицинской помощи, в Российской Федерации. Контроль и профилактика инфекций, связанных с оказанием медицинской помощи (ИСМП-2020). Cборник тезисов VIII Конгресса с международным участием (25-27 ноября 2020 г., Москва). М., 2020. 80 с.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies